IPP Bureau
Strides Pharma Science to invest in AMP-6, AMP-8
By IPP Bureau - January 03, 2024
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
Dr. Reddy's acquires MenoLabs
By IPP Bureau - January 03, 2024
Glenmark to launch biosimilar of anti-diabetic drug Liraglutide in India
By IPP Bureau - January 03, 2024
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Healthcare Triangle completes US$2 million private placement debt offering
By IPP Bureau - January 03, 2024
The company received gross proceeds of approximately US$1.7 million and net proceeds,
WuXi XDC partners with IntoCell to accelerate ADC discovery and development
By IPP Bureau - January 03, 2024
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases
By IPP Bureau - January 03, 2024
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
Cell and gene therapy will be top industry trend for pharma in 2024, finds GlobalData
By IPP Bureau - January 02, 2024
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Palatin completes sale of Vyleesi to Cosette Pharmaceuticals for up to $171 mn
By IPP Bureau - January 02, 2024
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Enpro to acquire Advanced Micro Instruments
By IPP Bureau - January 02, 2024
AMI to become part of Enpro’s Sealing Technologies Segment
Inspira Technologies closes on $3.88 million RDO
By IPP Bureau - January 02, 2024
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
Ami Organics increases its stake by 1%
By IPP Bureau - January 02, 2024
Ami Organics recently announced contract with global MNC for manufacturing of electrolyte for battery cells
Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 mn
By IPP Bureau - January 02, 2024
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
Roche to buy LumiraDx’s technology platform for US$ 295 million
By IPP Bureau - December 31, 2023
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Alkem completes sale of St. Louis manufacturing facility for US$ 7.96 million
By IPP Bureau - December 31, 2023
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
Adani and Sirius form JV to digitally transform India's digital economy
By IPP Bureau - December 31, 2023
Sirius JV will be owned 51% by Sirius and 49% by Adani
